Medicine
Mircera 250 mcg/1 mL injection
Mircera 250 mcg/1 mL injection is a prescription medicine containing Methoxy polyethylene glycol-epoetin beta for intravenous use, marketed by Vifor (International), with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
Store Mircera refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton…
Key facts
- Active ingredient (INN)
- Methoxy polyethylene glycol-epoetin beta
- Brand
- Mircera
- Strength
- 250 mcg/1 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 1 syringe of 1 mL
- Marketing authorisation holder
- Vifor (International)
- Manufacturer
- Vifor (International)
- Origin register
- US FDA, United States
- Storage
- Store Mircera refrigerated at 2°C to 8°C (36°F to 46°F) in the original carton to protect from light. Do not freeze or shake. The end-user may store the product at room temperature up to 25°C (77°F) in the original carton up to 30 days.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B03XA03 Methoxy polyethylene glycol-epoetin beta
- HS code (indicative)
- 3002.15Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 24 October 2014
- Identifiers
- RxCUI 758159, 758160, 758162 +7DailyMed set ID 22c56f2a-f73c-60e7-e054-00144ff88e88NDC 59353-402Application BLA125164
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 syringe, glass in 1 carton / 1 mL in 1 syringe, glass | 59353-402-09 | Vifor (International) | 24 October 2014 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Methoxy polyethylene glycol-epoetin beta
Clinical summary
Methoxy polyethylene glycol-epoetin beta is an erythropoiesis-stimulating agent indicated for the treatment of anemia associated with chronic kidney disease (CKD) in adult patients on dialysis and adult patients not on dialysis. MedsAcross supplies Methoxy polyethylene glycol-epoetin beta for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Methoxy polyethylene glycol-epoetin betaFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mircera prescribing information (Vifor (International)) · U.S. National Library of Medicine, DailyMed
- Mircera: European public assessment report (EPAR) · European Medicines Agency
Need Mircera 250 mcg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.